If symptoms become persistent or concerning, seeking professional advice can help identify the cause and ensure you receive appropriate support throughout your treatment journey
Eli Lilly expects to launch the medicine around the world around this time next year
In the JAMA Ophthalmology study, researchers included records of more than 510,000 patients in a national database, about half who were prescribed GLP-1 medication and half who were not
Use our Plotter to visualize the concentration of your GLP-1 Receptor Agonist over time
The administration of GLP-1RA exendin-4 restored microglial homeostasis, reduced cytokine secretion, and limited astrocyte activation, especially of the A1 phenotype, as well as reduced neuronal apoptosis
For plan sponsors, the challenge is no longer whether GLP-1 demand will grow, but how to structure coverage, clinical criteria, and utilization controls in a way that supports access while keeping long-term costs sustainable